access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Transplant Immunobiology Research


Dr. Satish Nadig (center) and Dr. Carl Atkinson (far right) discuss their research with a postgraduate scholar

The research focus of the Lee Patterson Allen Transplant Immunobiology Laboratory is dedicated  to investigating novel innovations in transplant research. As a comprehensive research enterprise, we are interested in all aspects of transplantation spanning donor organ management to the induction of allograft tolerance. In addition, we are also investigating techniques that will lead to the next era of transplantation including bioengineering and artificial tissue development. 

Organ transplantation has become an accepted modality for the treatment of end-stage organ failure. The field of transplant medicine has made tremendous strides within the last thirty years, allowing for newer, more potent immunosuppressive medications rendering acute rejection episodes less frequent and less aggressive.

In spite of these accomplishments, chronic rejection remains a leading cause of graft loss in the long term. Various translational research efforts have identified pathways and potential therapeutics that may allay the effects of chronic rejection by conferring a tolerogenic phenotype in allograft recipients both in mouse and man. 

The Lee Patterson Allen Transplant Immunobiology Laboratory, led by Drs. Nadig and Atkinson, is dedicated to the study of innovative methods focused on tolerance induction in transplanted allografts.


Satish Nadig, M.D., Ph.D.
Research on PubMed

Carl Atkinson Ph.D.
Research on PubMed

Research Scientists

David J. Taber, Pharm.D., BCPS: Dr. Taber's research focuses on optimizing transplant medication safety through Pharmacist-led mHealth based intervention. He is the PI of a $1,492,135 R18 study with the U.S. Department of Health & Human Services, Agency for Healthcare Research and Quality (AHRQ) 

John McGillicuddy, M.D.: Dr. McGillicuddy's research focuses on research to increase kidney transplant recipient graft survival. Dr.McGillicuddy is the PI of a $1.11 million National Institutes of Health grant to examine a novel use of mobile health technology to reduce kidney transplant recipient premature graft loss.

Research on PubMed

South Carolina Investigators in Transplantation: The South Carolina Investigators in Transplantation (SCIT) is comprised of a group of basic science and translational investigators whose laboratories have a specific focus in transplant immunology. 

MUSC Pediatric Transplant Program: The MUSC Health Transplant Center offers the most advanced pediatric transplant resources, facilities, and physicians skilled in the latest techniques, all focused on saving and improving the quality of young lives.